{
  "question_stem": {
    "en": "A 72-year-old woman comes to the office for a routine follow-up visit accompanied by her son. The patient has experienced progressive memory loss over the last 2 years. She now needs help with her daily activities, such as shopping and housekeeping. The patient's son says, \"She used to be such an independent person, but now she needs help with most things. She even forgot my name the other day!\" Medical history includes hypertension, hyperlipidemia, and type 2 diabetes mellitus. Family history includes major depressive disorder in her father. MRI reveals diffuse cortical and hippocampal atrophy. Which of the following biochemical changes is most likely contributing to this patient's condition?",
    "zh": "一位72岁的女性前来就诊，进行例行复诊，由她的儿子陪同。患者在过去2年内经历了进行性记忆力减退。她现在需要帮助进行日常活动，例如购物和家务。患者的儿子说：“她曾经是如此独立的人，但现在她需要帮助做大多数事情。她前几天甚至忘记了我的名字！” 病史包括高血压、高脂血症和2型糖尿病。 家族史包括她父亲患有重度抑郁症。 MRI显示弥漫性皮质和海马萎缩。 以下哪种生化改变最有可能导致患者的病情？"
  },
  "question": {
    "en": "Which of the following biochemical changes is most likely contributing to this patient's condition?",
    "zh": "以下哪种生化改变最有可能导致患者的病情？"
  },
  "options": {
    "A": {
      "en": "Decreased choline acetyltransferase activity in the nucleus basalis",
      "zh": "基底核内胆碱乙酰转移酶活性降低"
    },
    "B": {
      "en": "Decreased dopa decarboxylase activity in the substantia nigra",
      "zh": "黑质多巴脱羧酶活性降低"
    },
    "C": {
      "en": "Decreased tryptophan hydroxylase activity in the raphe nuclei",
      "zh": "中缝核色氨酸羟化酶活性降低"
    },
    "D": {
      "en": "Increased acetylcholinesterase activity in the caudate nucleus",
      "zh": "尾状核乙酰胆碱酯酶活性升高"
    },
    "E": {
      "en": "Increased dopamine beta-hydroxylase activity in the locus ceruleus",
      "zh": "蓝斑多巴胺β-羟化酶活性升高"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "The patient's presentation of progressive memory loss, difficulty with daily activities, and forgetting names, along with MRI findings of diffuse cortical and hippocampal atrophy, is highly suggestive of ALZHEIMER DISEASE (AD). AD is the most common cause of dementia, characterized by a decline in cognitive function, particularly memory. The underlying pathology involves the accumulation of amyloid plaques and neurofibrillary tangles, leading to neuronal dysfunction and death. \n\nBiochemically, AD is associated with a significant deficit in CHOLINERGIC neurotransmission. Specifically, there is a marked decrease in the synthesis of ACETYLCHOLINE, a neurotransmitter crucial for memory and learning. This deficiency is primarily due to the loss of cholinergic neurons in the NUCLEUS BASALIS OF MEYNERT, a structure located in the basal forebrain that projects widely to the cerebral cortex and hippocampus. The enzyme responsible for synthesizing acetylcholine is choline acetyltransferase, and its activity is reduced in AD. Therefore, decreased choline acetyltransferase activity in the nucleus basalis is the most likely biochemical change contributing to this patient's condition.\n\n(Choice B) Decreased dopa decarboxylase activity in the substantia nigra is associated with PARKINSON DISEASE, which is characterized by motor symptoms such as tremor, rigidity, and bradykinesia, due to the loss of dopaminergic neurons. While some patients with Parkinson disease can develop dementia (Dementia with Lewy Bodies), the primary deficit is dopaminergic, not cholinergic, and the typical presentation differs.\n\n(Choice C) Decreased tryptophan hydroxylase activity in the raphe nuclei would lead to reduced serotonin synthesis. Serotonin plays a role in mood, sleep, and appetite, and alterations in serotonergic pathways are implicated in depression and anxiety disorders, but not as the primary cause of memory loss in AD.\n\n(Choice D) Increased acetylcholinesterase activity would lead to increased breakdown of acetylcholine, exacerbating cholinergic deficiency. However, the primary issue in AD is reduced synthesis, not increased breakdown, and the caudate nucleus is not the primary site of cholinergic deficit in AD.\n\n(Choice E) Increased dopamine beta-hydroxylase activity in the locus ceruleus would lead to increased norepinephrine synthesis. The locus ceruleus is involved in arousal and attention, and while noradrenergic pathways can be affected in dementia, the primary and most significant biochemical abnormality in AD is the cholinergic deficit.\n\nKey clinical pearls:\n- ALZHEIMER DISEASE is characterized by progressive memory loss and cognitive decline.\n- MRI findings of CORTICAL and HIPPOCAMPAL ATROPHY are typical.\n- The most significant biochemical abnormality in AD is the DEFICIENCY of ACETYLCHOLINE due to loss of neurons in the NUCLEUS BASALIS OF MEYNERT.\n- CHOLINE ACETYLTRANSFERASE is the enzyme responsible for acetylcholine synthesis and is decreased in AD.\n- Symptomatic treatment for AD often involves CHOLINESTERASE INHIBITORS to increase acetylcholine levels.",
    "zh": "患者出现进行性记忆力减退、日常活动困难以及忘记名字的表现，加上MRI显示弥漫性皮质和海马萎缩，高度提示为阿尔茨海默病 (AD)。 AD是痴呆最常见的原因，其特征是认知功能下降，尤其是记忆力。 潜在的病理学涉及淀粉样斑块和神经原纤维缠结的积累，导致神经元功能障碍和死亡。\n\n从生化角度看，AD 与胆碱能神经传递的显著缺陷有关。 具体而言，乙酰胆碱的合成显着减少，乙酰胆碱是一种对记忆和学习至关重要的神经递质。 这种缺陷主要是由于 Meynert 基底核中胆碱能神经元的丧失，Meynert 基底核位于基底前脑，广泛投射到大脑皮层和海马。 负责合成乙酰胆碱的酶是胆碱乙酰转移酶，其活性在AD中降低。 因此，基底核中胆碱乙酰转移酶活性的降低最有可能导致该患者的生化改变。\n\n(选项 B) 黑质中多巴脱羧酶活性的降低与帕金森病相关，其特征是震颤、僵硬和运动迟缓等运动症状，这是由于多巴胺能神经元的丢失所致。 虽然一些帕金森病患者可能会发展为痴呆（路易体痴呆），但主要的缺陷是多巴胺能的，而不是胆碱能的，而且典型的表现不同。\n\n(选项 C) 中缝核中色氨酸羟化酶活性的降低会导致血清素合成减少。 血清素在情绪、睡眠和食欲中起作用，血清素能通路的改变与抑郁症和焦虑症有关，但不是 AD 记忆力减退的主要原因。\n\n(选项 D) 尾状核中乙酰胆碱酯酶活性的升高会导致乙酰胆碱分解增加，加剧胆碱能缺陷。 然而，AD 中的主要问题是合成减少，而不是分解增加，并且尾状核不是 AD 中胆碱能缺陷的主要部位。\n\n(选项 E) 蓝斑中多巴胺 β-羟化酶活性的升高会导致去甲肾上腺素合成增加。 蓝斑与唤醒和注意力有关，虽然痴呆症中可以影响去甲肾上腺素能通路，但 AD 中主要的和最重要的生化异常是胆碱能缺陷。\n\n关键临床要点：\n- 阿尔茨海默病以进行性记忆力减退和认知能力下降为特征。\n- 皮质和海马萎缩的 MRI 发现是典型的。\n- AD 中最显着的生化异常是由于 Meynert 基底核神经元丢失导致的乙酰胆碱缺乏。\n- 胆碱乙酰转移酶是负责乙酰胆碱合成的酶，在 AD 中降低。\n- AD 的对症治疗通常涉及胆碱酯酶抑制剂以增加乙酰胆碱水平。"
  },
  "summary": {
    "en": "This question tests the understanding of the underlying biochemical abnormalities in Alzheimer disease, specifically focusing on the neurotransmitter deficits that contribute to the cognitive decline. It requires correlating clinical presentation and imaging findings with specific neurochemical changes.\n\nTo solve this question, one must first recognize the clinical features and imaging findings suggestive of Alzheimer disease. Then, recall the key neurotransmitter system affected in AD, which is the cholinergic system, and identify the specific enzyme and neuronal population involved in this deficit.",
    "zh": "这个问题考察了对阿尔茨海默病潜在生化异常的理解，特别是侧重于导致认知能力下降的神经递质缺陷。 它需要将临床表现和影像学发现与特定的神经化学变化相关联。\n\n要解决这个问题，首先必须识别提示阿尔茨海默病的临床特征和影像学发现。 然后，回忆起受 AD 影响的关键神经递质系统，即胆碱能系统，并确定参与此缺陷的特定酶和神经元群体。"
  },
  "tags": "Alzheimer disease; Dementia; Cholinergic deficit; Nucleus basalis of Meynert; Choline acetyltransferase; Acetylcholine; Neurochemistry; Neurology; Geriatrics",
  "category": "Neuro",
  "question_id": "593",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Neuro 24\\593",
  "extracted_at": "2025-11-05T19:40:34.456053",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:41:38.369132",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}